## ValueSet Comparison between http://hl7.org/fhir/ValueSet/vaccine-code vs http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6

### Messages

Error | ValueSet.url | Values for url differ: 'http://hl7.org/fhir/ValueSet/vaccine-code' vs 'http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6'
Error | ValueSet.version | Values for version differ: '4.0.1' vs '20250411'
Information | ValueSet.name | Values for name differ: 'VaccineAdministeredValueSet' vs 'CVXVaccinesAdministeredVaccineSet'
Information | ValueSet.title | Values for title differ: 'Vaccine Administered Value Set' vs 'CVX Vaccines Administered Vaccine Set'
Information | ValueSet.date | Values for date differ: '2019-11-01T09:29:23+11:00' vs '2025-04-11T01:08:38-04:00'
Information | ValueSet.publisher | Values for publisher differ: 'HL7 FHIR' vs 'HL7 US Realm Program Management Steward'
Information | ValueSet.jurisdiction | Added the item 'urn:iso:std:iso:3166#US'
Error | ValueSet.compose.include[0] | Code 01 added
Error | ValueSet.compose.include[0] | Code 02 added
Error | ValueSet.compose.include[0] | Code 03 added
Error | ValueSet.compose.include[0] | Code 04 added
Error | ValueSet.compose.include[0] | Code 05 added
Error | ValueSet.compose.include[0] | Code 06 added
Error | ValueSet.compose.include[0] | Code 07 added
Error | ValueSet.compose.include[0] | Code 08 added
Error | ValueSet.compose.include[0] | Code 09 added
Error | ValueSet.compose.include[0] | Code 10 added
Error | ValueSet.compose.include[0] | Code 100 added
Error | ValueSet.compose.include[0] | Code 101 added
Error | ValueSet.compose.include[0] | Code 102 added
Error | ValueSet.compose.include[0] | Code 103 added
Error | ValueSet.compose.include[0] | Code 104 added
Error | ValueSet.compose.include[0] | Code 105 added
Error | ValueSet.compose.include[0] | Code 106 added
Error | ValueSet.compose.include[0] | Code 107 added
Error | ValueSet.compose.include[0] | Code 108 added
Error | ValueSet.compose.include[0] | Code 109 added
Error | ValueSet.compose.include[0] | Code 11 added
Error | ValueSet.compose.include[0] | Code 110 added
Error | ValueSet.compose.include[0] | Code 111 added
Error | ValueSet.compose.include[0] | Code 112 added
Error | ValueSet.compose.include[0] | Code 113 added
Error | ValueSet.compose.include[0] | Code 114 added
Error | ValueSet.compose.include[0] | Code 115 added
Error | ValueSet.compose.include[0] | Code 116 added
Error | ValueSet.compose.include[0] | Code 118 added
Error | ValueSet.compose.include[0] | Code 119 added
Error | ValueSet.compose.include[0] | Code 120 added
Error | ValueSet.compose.include[0] | Code 121 added
Error | ValueSet.compose.include[0] | Code 122 added
Error | ValueSet.compose.include[0] | Code 123 added
Error | ValueSet.compose.include[0] | Code 125 added
Error | ValueSet.compose.include[0] | Code 126 added
Error | ValueSet.compose.include[0] | Code 127 added
Error | ValueSet.compose.include[0] | Code 128 added
Error | ValueSet.compose.include[0] | Code 129 added
Error | ValueSet.compose.include[0] | Code 130 added
Error | ValueSet.compose.include[0] | Code 131 added
Error | ValueSet.compose.include[0] | Code 132 added
Error | ValueSet.compose.include[0] | Code 133 added
Error | ValueSet.compose.include[0] | Code 134 added
Error | ValueSet.compose.include[0] | Code 135 added
Error | ValueSet.compose.include[0] | Code 136 added
Error | ValueSet.compose.include[0] | Code 137 added
Error | ValueSet.compose.include[0] | Code 138 added
Error | ValueSet.compose.include[0] | Code 139 added
Error | ValueSet.compose.include[0] | Code 140 added
Error | ValueSet.compose.include[0] | Code 141 added
Error | ValueSet.compose.include[0] | Code 142 added
Error | ValueSet.compose.include[0] | Code 143 added
Error | ValueSet.compose.include[0] | Code 144 added
Error | ValueSet.compose.include[0] | Code 146 added
Error | ValueSet.compose.include[0] | Code 147 added
Error | ValueSet.compose.include[0] | Code 148 added
Error | ValueSet.compose.include[0] | Code 149 added
Error | ValueSet.compose.include[0] | Code 15 added
Error | ValueSet.compose.include[0] | Code 150 added
Error | ValueSet.compose.include[0] | Code 151 added
Error | ValueSet.compose.include[0] | Code 152 added
Error | ValueSet.compose.include[0] | Code 153 added
Error | ValueSet.compose.include[0] | Code 155 added
Error | ValueSet.compose.include[0] | Code 158 added
Error | ValueSet.compose.include[0] | Code 16 added
Error | ValueSet.compose.include[0] | Code 160 added
Error | ValueSet.compose.include[0] | Code 161 added
Error | ValueSet.compose.include[0] | Code 162 added
Error | ValueSet.compose.include[0] | Code 163 added
Error | ValueSet.compose.include[0] | Code 164 added
Error | ValueSet.compose.include[0] | Code 165 added
Error | ValueSet.compose.include[0] | Code 166 added
Error | ValueSet.compose.include[0] | Code 167 added
Error | ValueSet.compose.include[0] | Code 168 added
Error | ValueSet.compose.include[0] | Code 169 added
Error | ValueSet.compose.include[0] | Code 17 added
Error | ValueSet.compose.include[0] | Code 170 added
Error | ValueSet.compose.include[0] | Code 171 added
Error | ValueSet.compose.include[0] | Code 172 added
Error | ValueSet.compose.include[0] | Code 173 added
Error | ValueSet.compose.include[0] | Code 174 added
Error | ValueSet.compose.include[0] | Code 175 added
Error | ValueSet.compose.include[0] | Code 176 added
Error | ValueSet.compose.include[0] | Code 177 added
Error | ValueSet.compose.include[0] | Code 178 added
Error | ValueSet.compose.include[0] | Code 179 added
Error | ValueSet.compose.include[0] | Code 18 added
Error | ValueSet.compose.include[0] | Code 182 added
Error | ValueSet.compose.include[0] | Code 183 added
Error | ValueSet.compose.include[0] | Code 184 added
Error | ValueSet.compose.include[0] | Code 185 added
Error | ValueSet.compose.include[0] | Code 186 added
Error | ValueSet.compose.include[0] | Code 187 added
Error | ValueSet.compose.include[0] | Code 188 added
Error | ValueSet.compose.include[0] | Code 189 added
Error | ValueSet.compose.include[0] | Code 19 added
Error | ValueSet.compose.include[0] | Code 190 added
Error | ValueSet.compose.include[0] | Code 191 added
Error | ValueSet.compose.include[0] | Code 192 added
Error | ValueSet.compose.include[0] | Code 193 added
Error | ValueSet.compose.include[0] | Code 194 added
Error | ValueSet.compose.include[0] | Code 195 added
Error | ValueSet.compose.include[0] | Code 196 added
Error | ValueSet.compose.include[0] | Code 197 added
Error | ValueSet.compose.include[0] | Code 198 added
Error | ValueSet.compose.include[0] | Code 20 added
Error | ValueSet.compose.include[0] | Code 200 added
Error | ValueSet.compose.include[0] | Code 201 added
Error | ValueSet.compose.include[0] | Code 202 added
Error | ValueSet.compose.include[0] | Code 203 added
Error | ValueSet.compose.include[0] | Code 204 added
Error | ValueSet.compose.include[0] | Code 205 added
Error | ValueSet.compose.include[0] | Code 206 added
Error | ValueSet.compose.include[0] | Code 207 added
Error | ValueSet.compose.include[0] | Code 208 added
Error | ValueSet.compose.include[0] | Code 21 added
Error | ValueSet.compose.include[0] | Code 210 added
Error | ValueSet.compose.include[0] | Code 211 added
Error | ValueSet.compose.include[0] | Code 212 added
Error | ValueSet.compose.include[0] | Code 213 added
Error | ValueSet.compose.include[0] | Code 214 added
Error | ValueSet.compose.include[0] | Code 215 added
Error | ValueSet.compose.include[0] | Code 216 added
Error | ValueSet.compose.include[0] | Code 217 added
Error | ValueSet.compose.include[0] | Code 218 added
Error | ValueSet.compose.include[0] | Code 219 added
Error | ValueSet.compose.include[0] | Code 22 added
Error | ValueSet.compose.include[0] | Code 220 added
Error | ValueSet.compose.include[0] | Code 221 added
Error | ValueSet.compose.include[0] | Code 222 added
Error | ValueSet.compose.include[0] | Code 223 added
Error | ValueSet.compose.include[0] | Code 224 added
Error | ValueSet.compose.include[0] | Code 227 added
Error | ValueSet.compose.include[0] | Code 228 added
Error | ValueSet.compose.include[0] | Code 229 added
Error | ValueSet.compose.include[0] | Code 23 added
Error | ValueSet.compose.include[0] | Code 230 added
Error | ValueSet.compose.include[0] | Code 231 added
Error | ValueSet.compose.include[0] | Code 24 added
Error | ValueSet.compose.include[0] | Code 25 added
Error | ValueSet.compose.include[0] | Code 26 added
Error | ValueSet.compose.include[0] | Code 28 added
Error | ValueSet.compose.include[0] | Code 300 added
Error | ValueSet.compose.include[0] | Code 301 added
Error | ValueSet.compose.include[0] | Code 302 added
Error | ValueSet.compose.include[0] | Code 303 added
Error | ValueSet.compose.include[0] | Code 304 added
Error | ValueSet.compose.include[0] | Code 305 added
Error | ValueSet.compose.include[0] | Code 306 added
Error | ValueSet.compose.include[0] | Code 307 added
Error | ValueSet.compose.include[0] | Code 308 added
Error | ValueSet.compose.include[0] | Code 309 added
Error | ValueSet.compose.include[0] | Code 31 added
Error | ValueSet.compose.include[0] | Code 310 added
Error | ValueSet.compose.include[0] | Code 311 added
Error | ValueSet.compose.include[0] | Code 312 added
Error | ValueSet.compose.include[0] | Code 313 added
Error | ValueSet.compose.include[0] | Code 314 added
Error | ValueSet.compose.include[0] | Code 315 added
Error | ValueSet.compose.include[0] | Code 316 added
Error | ValueSet.compose.include[0] | Code 317 added
Error | ValueSet.compose.include[0] | Code 318 added
Error | ValueSet.compose.include[0] | Code 319 added
Error | ValueSet.compose.include[0] | Code 32 added
Error | ValueSet.compose.include[0] | Code 320 added
Error | ValueSet.compose.include[0] | Code 321 added
Error | ValueSet.compose.include[0] | Code 322 added
Error | ValueSet.compose.include[0] | Code 323 added
Error | ValueSet.compose.include[0] | Code 324 added
Error | ValueSet.compose.include[0] | Code 326 added
Error | ValueSet.compose.include[0] | Code 327 added
Error | ValueSet.compose.include[0] | Code 33 added
Error | ValueSet.compose.include[0] | Code 35 added
Error | ValueSet.compose.include[0] | Code 37 added
Error | ValueSet.compose.include[0] | Code 38 added
Error | ValueSet.compose.include[0] | Code 39 added
Error | ValueSet.compose.include[0] | Code 40 added
Error | ValueSet.compose.include[0] | Code 41 added
Error | ValueSet.compose.include[0] | Code 42 added
Error | ValueSet.compose.include[0] | Code 43 added
Error | ValueSet.compose.include[0] | Code 44 added
Error | ValueSet.compose.include[0] | Code 45 added
Error | ValueSet.compose.include[0] | Code 46 added
Error | ValueSet.compose.include[0] | Code 47 added
Error | ValueSet.compose.include[0] | Code 48 added
Error | ValueSet.compose.include[0] | Code 49 added
Error | ValueSet.compose.include[0] | Code 50 added
Error | ValueSet.compose.include[0] | Code 500 added
Error | ValueSet.compose.include[0] | Code 501 added
Error | ValueSet.compose.include[0] | Code 502 added
Error | ValueSet.compose.include[0] | Code 503 added
Error | ValueSet.compose.include[0] | Code 504 added
Error | ValueSet.compose.include[0] | Code 505 added
Error | ValueSet.compose.include[0] | Code 506 added
Error | ValueSet.compose.include[0] | Code 507 added
Error | ValueSet.compose.include[0] | Code 508 added
Error | ValueSet.compose.include[0] | Code 509 added
Error | ValueSet.compose.include[0] | Code 51 added
Error | ValueSet.compose.include[0] | Code 510 added
Error | ValueSet.compose.include[0] | Code 511 added
Error | ValueSet.compose.include[0] | Code 512 added
Error | ValueSet.compose.include[0] | Code 513 added
Error | ValueSet.compose.include[0] | Code 514 added
Error | ValueSet.compose.include[0] | Code 515 added
Error | ValueSet.compose.include[0] | Code 516 added
Error | ValueSet.compose.include[0] | Code 517 added
Error | ValueSet.compose.include[0] | Code 518 added
Error | ValueSet.compose.include[0] | Code 519 added
Error | ValueSet.compose.include[0] | Code 52 added
Error | ValueSet.compose.include[0] | Code 520 added
Error | ValueSet.compose.include[0] | Code 521 added
Error | ValueSet.compose.include[0] | Code 53 added
Error | ValueSet.compose.include[0] | Code 54 added
Error | ValueSet.compose.include[0] | Code 55 added
Error | ValueSet.compose.include[0] | Code 56 added
Error | ValueSet.compose.include[0] | Code 62 added
Error | ValueSet.compose.include[0] | Code 66 added
Error | ValueSet.compose.include[0] | Code 69 added
Error | ValueSet.compose.include[0] | Code 74 added
Error | ValueSet.compose.include[0] | Code 75 added
Error | ValueSet.compose.include[0] | Code 77 added
Error | ValueSet.compose.include[0] | Code 78 added
Error | ValueSet.compose.include[0] | Code 80 added
Error | ValueSet.compose.include[0] | Code 81 added
Error | ValueSet.compose.include[0] | Code 82 added
Error | ValueSet.compose.include[0] | Code 83 added
Error | ValueSet.compose.include[0] | Code 84 added
Error | ValueSet.compose.include[0] | Code 85 added
Error | ValueSet.compose.include[0] | Code 88 added
Error | ValueSet.compose.include[0] | Code 89 added
Error | ValueSet.compose.include[0] | Code 90 added
Error | ValueSet.compose.include[0] | Code 91 added
Error | ValueSet.compose.include[0] | Code 92 added
Error | ValueSet.compose.include[0] | Code 94 added

### Metadata

Name | Value | Comments
--- | --- | ---
compose.inactive |  |
compose.lockedDate |  |
copyright |  |
date | 2019-11-01T09:29:23+11:00 | 2025-04-11T01:08:38-04:00 | Values Differ
description | This identifies the vaccine substance administered - CVX codes. |  | Removed the item 'This identifies the vaccine substance administered - CVX codes.'
experimental | false |  | Removed the item 'false'
immutable |  |
jurisdiction |  |
jurisdiction[0] |  | urn:iso:std:iso:3166#US | Added the item 'urn:iso:std:iso:3166#US'
name | VaccineAdministeredValueSet | CVXVaccinesAdministeredVaccineSet | Values Differ
publisher | HL7 FHIR | HL7 US Realm Program Management Steward | Values Differ
purpose |  | (Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.) | Added the item '(Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.)'
status | active |
title | Vaccine Administered Value Set | CVX Vaccines Administered Vaccine Set | Values Differ
url | http://hl7.org/fhir/ValueSet/vaccine-code | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 | Values Differ
version | 4.0.1 | 20250411 | Values Differ

### Definition

Item | Property | Value | Comments
--- | --- | --- | ---
include | http://hl7.org/fhir/sid/cvx |  |
Concept |  | 01 |  | Version: diphtheria, tetanus toxoids and pertussis vaccine | Added this Concept
Concept |  | 02 |  | Version: trivalent poliovirus vaccine, live, oral | Added this Concept
Concept |  | 03 |  | Version: measles, mumps and rubella virus vaccine | Added this Concept
Concept |  | 04 |  | Version: measles and rubella virus vaccine | Added this Concept
Concept |  | 05 |  | Version: measles virus vaccine | Added this Concept
Concept |  | 06 |  | Version: rubella virus vaccine | Added this Concept
Concept |  | 07 |  | Version: mumps virus vaccine | Added this Concept
Concept |  | 08 |  | Version: hepatitis B vaccine, pediatric or pediatric/adolescent dosage | Added this Concept
Concept |  | 09 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | Added this Concept
Concept |  | 10 |  | Version: poliovirus vaccine, inactivated | Added this Concept
Concept |  | 100 |  | Version: pneumococcal conjugate vaccine, 7 valent | Added this Concept
Concept |  | 101 |  | Version: typhoid Vi capsular polysaccharide vaccine | Added this Concept
Concept |  | 102 |  | Version: DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | Added this Concept
Concept |  | 103 |  | Version: meningococcal C conjugate vaccine | Added this Concept
Concept |  | 104 |  | Version: hepatitis A and hepatitis B vaccine | Added this Concept
Concept |  | 105 |  | Version: vaccinia (smallpox) vaccine, diluted | Added this Concept
Concept |  | 106 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | Added this Concept
Concept |  | 107 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | Added this Concept
Concept |  | 108 |  | Version: meningococcal ACWY vaccine, unspecified formulation | Added this Concept
Concept |  | 109 |  | Version: pneumococcal vaccine, unspecified formulation | Added this Concept
Concept |  | 11 |  | Version: pertussis vaccine | Added this Concept
Concept |  | 110 |  | Version: DTaP-hepatitis B and poliovirus vaccine | Added this Concept
Concept |  | 111 |  | Version: Influenza, live, trivalent, intranasal | Added this Concept
Concept |  | 112 |  | Version: tetanus toxoid, unspecified formulation | Added this Concept
Concept |  | 113 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | Added this Concept
Concept |  | 114 |  | Version: meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | Added this Concept
Concept |  | 115 |  | Version: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | Added this Concept
Concept |  | 116 |  | Version: rotavirus, live, pentavalent vaccine | Added this Concept
Concept |  | 118 |  | Version: human papilloma virus vaccine, bivalent | Added this Concept
Concept |  | 119 |  | Version: rotavirus, live, monovalent vaccine | Added this Concept
Concept |  | 120 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | Added this Concept
Concept |  | 121 |  | Version: zoster vaccine, live | Added this Concept
Concept |  | 122 |  | Version: rotavirus vaccine, unspecified formulation | Added this Concept
Concept |  | 123 |  | Version: influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | Added this Concept
Concept |  | 125 |  | Version: Novel Influenza-H1N1-09, live virus for nasal administration | Added this Concept
Concept |  | 126 |  | Version: Novel influenza-H1N1-09, preservative-free, injectable | Added this Concept
Concept |  | 127 |  | Version: Novel influenza-H1N1-09, injectable | Added this Concept
Concept |  | 128 |  | Version: Novel influenza-H1N1-09, all formulations | Added this Concept
Concept |  | 129 |  | Version: Japanese Encephalitis vaccine, unspecified formulation | Added this Concept
Concept |  | 130 |  | Version: Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | Added this Concept
Concept |  | 131 |  | Version: Historical record of a typhus vaccination | Added this Concept
Concept |  | 132 |  | Version: Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. | Added this Concept
Concept |  | 133 |  | Version: pneumococcal conjugate vaccine, 13 valent | Added this Concept
Concept |  | 134 |  | Version: Japanese Encephalitis vaccine for intramuscular administration | Added this Concept
Concept |  | 135 |  | Version: Influenza, high-dose, split virus, trivalent, injectable, preservative free | Added this Concept
Concept |  | 136 |  | Version: meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | Added this Concept
Concept |  | 137 |  | Version: HPV, unspecified formulation | Added this Concept
Concept |  | 138 |  | Version: tetanus and diphtheria toxoids, not adsorbed, for adult use | Added this Concept
Concept |  | 139 |  | Version: Td(adult) unspecified formulation | Added this Concept
Concept |  | 140 |  | Version: Influenza, split virus, trivalent, injectable, preservative free | Added this Concept
Concept |  | 141 |  | Version: Influenza, split virus, trivalent, injectable, contains preservative | Added this Concept
Concept |  | 142 |  | Version: tetanus toxoid, not adsorbed | Added this Concept
Concept |  | 143 |  | Version: Adenovirus, type 4 and type 7, live, oral | Added this Concept
Concept |  | 144 |  | Version: seasonal influenza, intradermal, preservative free | Added this Concept
Concept |  | 146 |  | Version: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. | Added this Concept
Concept |  | 147 |  | Version: Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | Added this Concept
Concept |  | 148 |  | Version: Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | Added this Concept
Concept |  | 149 |  | Version: Influenza, live, quadrivalent, intranasal | Added this Concept
Concept |  | 15 |  | Version: influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | Added this Concept
Concept |  | 150 |  | Version: Influenza, split virus, quadrivalent, injectable, preservative free | Added this Concept
Concept |  | 151 |  | Version: influenza nasal, unspecified formulation | Added this Concept
Concept |  | 152 |  | Version: Pneumococcal Conjugate, unspecified formulation | Added this Concept
Concept |  | 153 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free | Added this Concept
Concept |  | 155 |  | Version: Influenza, recombinant, trivalent, injectable, preservative free | Added this Concept
Concept |  | 158 |  | Version: Influenza, split virus, quadrivalent, injectable, contains preservative | Added this Concept
Concept |  | 16 |  | Version: influenza virus vaccine, whole virus | Added this Concept
Concept |  | 160 |  | Version: Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | Added this Concept
Concept |  | 161 |  | Version: Influenza, injectable,quadrivalent, preservative free, pediatric | Added this Concept
Concept |  | 162 |  | Version: meningococcal B vaccine, fully recombinant | Added this Concept
Concept |  | 163 |  | Version: meningococcal B vaccine, recombinant, OMV, adjuvanted | Added this Concept
Concept |  | 164 |  | Version: meningococcal B, unspecified formulation | Added this Concept
Concept |  | 165 |  | Version: Human Papillomavirus 9-valent vaccine | Added this Concept
Concept |  | 166 |  | Version: influenza, intradermal, quadrivalent, preservative free, injectable | Added this Concept
Concept |  | 167 |  | Version: meningococcal vaccine of unknown formulation and unknown serogroups | Added this Concept
Concept |  | 168 |  | Version: Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free | Added this Concept
Concept |  | 169 |  | Version: Hep A, live attenuated-IM | Added this Concept
Concept |  | 17 |  | Version: Haemophilus influenzae type b vaccine, conjugate unspecified formulation | Added this Concept
Concept |  | 170 |  | Version: non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | Added this Concept
Concept |  | 171 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free | Added this Concept
Concept |  | 172 |  | Version: cholera, WC-rBS | Added this Concept
Concept |  | 173 |  | Version: cholera, BivWC | Added this Concept
Concept |  | 174 |  | Version: cholera, live attenuated | Added this Concept
Concept |  | 175 |  | Version: Human Rabies vaccine from human diploid cell culture | Added this Concept
Concept |  | 176 |  | Version: Human rabies vaccine from Chicken fibroblast culture | Added this Concept
Concept |  | 177 |  | Version: pneumococcal conjugate vaccine, 10 valent | Added this Concept
Concept |  | 178 |  | Version: Non-US bivalent oral polio vaccine (types 1 and 3) | Added this Concept
Concept |  | 179 |  | Version: Non-US monovalent oral polio vaccine, unspecified formulation | Added this Concept
Concept |  | 18 |  | Version: rabies vaccine, for intramuscular injection RETIRED CODE | Added this Concept
Concept |  | 182 |  | Version: Oral Polio Vaccine, Unspecified formulation | Added this Concept
Concept |  | 183 |  | Version: Yellow fever vaccine live - alternative formulation for vaccine shortage | Added this Concept
Concept |  | 184 |  | Version: Yellow fever vaccine, unspecified formulation | Added this Concept
Concept |  | 185 |  | Version: Influenza, recombinant, quadrivalent, injectable, preservative free | Added this Concept
Concept |  | 186 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative | Added this Concept
Concept |  | 187 |  | Version: zoster vaccine recombinant | Added this Concept
Concept |  | 188 |  | Version: zoster vaccine, unspecified formulation | Added this Concept
Concept |  | 189 |  | Version: Hepatitis B vaccine (recombinant), CpG adjuvanted | Added this Concept
Concept |  | 19 |  | Version: Bacillus Calmette-Guerin vaccine | Added this Concept
Concept |  | 190 |  | Version: Typhoid conjugate vaccine (non-US) | Added this Concept
Concept |  | 191 |  | Version: meningococcal A polysaccharide vaccine (non-US) | Added this Concept
Concept |  | 192 |  | Version: meningococcal AC polysaccharide vaccine (non-US) | Added this Concept
Concept |  | 193 |  | Version: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) | Added this Concept
Concept |  | 194 |  | Version: influenza, Southern Hemisphere, unspecified formulation | Added this Concept
Concept |  | 195 |  | Version: Diphtheria, Tetanus, Poliomyelitis adsorbed | Added this Concept
Concept |  | 196 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified | Added this Concept
Concept |  | 197 |  | Version: Influenza, high-dose, split virus, quadrivalent, injectable, preservative free | Added this Concept
Concept |  | 198 |  | Version: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) | Added this Concept
Concept |  | 20 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine | Added this Concept
Concept |  | 200 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free | Added this Concept
Concept |  | 201 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative | Added this Concept
Concept |  | 202 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative | Added this Concept
Concept |  | 203 |  | Version: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free | Added this Concept
Concept |  | 204 |  | Version: Ebola Zaire vaccine, live, recombinant, 1mL dose | Added this Concept
Concept |  | 205 |  | Version: Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free | Added this Concept
Concept |  | 206 |  | Version: Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection | Added this Concept
Concept |  | 207 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | Added this Concept
Concept |  | 208 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose | Added this Concept
Concept |  | 21 |  | Version: varicella virus vaccine | Added this Concept
Concept |  | 210 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | Added this Concept
Concept |  | 211 |  | Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose | Added this Concept
Concept |  | 212 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL | Added this Concept
Concept |  | 213 |  | Version: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | Added this Concept
Concept |  | 214 |  | Version: Ebola, unspecified | Added this Concept
Concept |  | 215 |  | Version: Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free | Added this Concept
Concept |  | 216 |  | Version: Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free | Added this Concept
Concept |  | 217 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 218 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 219 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 22 |  | Version: DTP-Haemophilus influenzae type b conjugate vaccine | Added this Concept
Concept |  | 220 |  | Version: Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted | Added this Concept
Concept |  | 221 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose | Added this Concept
Concept |  | 222 |  | Version: Tick-borne encephalitis vaccine, unspecified | Added this Concept
Concept |  | 223 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose | Added this Concept
Concept |  | 224 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose | Added this Concept
Concept |  | 227 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose | Added this Concept
Concept |  | 228 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose | Added this Concept
Concept |  | 229 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose | Added this Concept
Concept |  | 23 |  | Version: plague vaccine | Added this Concept
Concept |  | 230 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose | Added this Concept
Concept |  | 231 |  | Version: influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free | Added this Concept
Concept |  | 24 |  | Version: Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis | Added this Concept
Concept |  | 25 |  | Version: typhoid vaccine, live, oral | Added this Concept
Concept |  | 26 |  | Version: cholera vaccine, unspecified formulation | Added this Concept
Concept |  | 28 |  | Version: diphtheria and tetanus toxoids, adsorbed for pediatric use | Added this Concept
Concept |  | 300 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 301 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 302 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation | Added this Concept
Concept |  | 303 |  | Version: Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free | Added this Concept
Concept |  | 304 |  | Version: Respiratory syncytial virus (RSV), unspecified | Added this Concept
Concept |  | 305 |  | Version: Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free | Added this Concept
Concept |  | 306 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months | Added this Concept
Concept |  | 307 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months | Added this Concept
Concept |  | 308 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose | Added this Concept
Concept |  | 309 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose | Added this Concept
Concept |  | 31 |  | Version: hepatitis A vaccine, pediatric dosage, unspecified formulation | Added this Concept
Concept |  | 310 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose | Added this Concept
Concept |  | 311 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose | Added this Concept
Concept |  | 312 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose | Added this Concept
Concept |  | 313 |  | Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose | Added this Concept
Concept |  | 314 |  | Version: Respiratory syncytial virus (RSV) vaccine, unspecified | Added this Concept
Concept |  | 315 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified | Added this Concept
Concept |  | 316 |  | Version: Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free | Added this Concept
Concept |  | 317 |  | Version: Chikungunya, live attenuated vaccine, 0.5 mL, preservative free | Added this Concept
Concept |  | 318 |  | Version: Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis | Added this Concept
Concept |  | 319 |  | Version: Anthrax vaccine, unspecified | Added this Concept
Concept |  | 32 |  | Version: meningococcal polysaccharide vaccine (MPSV4) | Added this Concept
Concept |  | 320 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative | Added this Concept
Concept |  | 321 |  | Version: Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free | Added this Concept
Concept |  | 322 |  | Version: Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative | Added this Concept
Concept |  | 323 |  | Version: Influenza-avian, H5, unspecified formulation | Added this Concept
Concept |  | 324 |  | Version: Poliovirus, inactivated, fractional-dose (fIPV) | Added this Concept
Concept |  | 326 |  | Version: Respiratory syncytial virus (RSV), mRNA, injectable, preservative free | Added this Concept
Concept |  | 327 |  | Version: Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free | Added this Concept
Concept |  | 33 |  | Version: pneumococcal polysaccharide vaccine, 23 valent | Added this Concept
Concept |  | 35 |  | Version: tetanus toxoid, adsorbed | Added this Concept
Concept |  | 37 |  | Version: yellow fever vaccine live | Added this Concept
Concept |  | 38 |  | Version: rubella and mumps virus vaccine | Added this Concept
Concept |  | 39 |  | Version: Japanese Encephalitis Vaccine SC | Added this Concept
Concept |  | 40 |  | Version: rabies vaccine, for intradermal injection | Added this Concept
Concept |  | 41 |  | Version: typhoid vaccine, parenteral, other than acetone-killed, dried | Added this Concept
Concept |  | 42 |  | Version: hepatitis B vaccine, adolescent/high risk infant dosage | Added this Concept
Concept |  | 43 |  | Version: hepatitis B vaccine, adult dosage | Added this Concept
Concept |  | 44 |  | Version: Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient | Added this Concept
Concept |  | 45 |  | Version: hepatitis B vaccine, unspecified formulation | Added this Concept
Concept |  | 46 |  | Version: Haemophilus influenzae type b vaccine, PRP-D conjugate | Added this Concept
Concept |  | 47 |  | Version: Haemophilus influenzae type b vaccine, HbOC conjugate | Added this Concept
Concept |  | 48 |  | Version: Haemophilus influenzae type b vaccine, PRP-T conjugate | Added this Concept
Concept |  | 49 |  | Version: Haemophilus influenzae type b vaccine, PRP-OMP conjugate | Added this Concept
Concept |  | 50 |  | Version: DTaP-Haemophilus influenzae type b conjugate vaccine | Added this Concept
Concept |  | 500 |  | Version: SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown | Added this Concept
Concept |  | 501 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) | Added this Concept
Concept |  | 502 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) | Added this Concept
Concept |  | 503 |  | Version: SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) | Added this Concept
Concept |  | 504 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) | Added this Concept
Concept |  | 505 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) | Added this Concept
Concept |  | 506 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology | Added this Concept
Concept |  | 507 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) | Added this Concept
Concept |  | 508 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) | Added this Concept
Concept |  | 509 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) | Added this Concept
Concept |  | 51 |  | Version: Haemophilus influenzae type b conjugate and Hepatitis B vaccine | Added this Concept
Concept |  | 510 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) | Added this Concept
Concept |  | 511 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) | Added this Concept
Concept |  | 512 |  | Version: SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) | Added this Concept
Concept |  | 513 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) | Added this Concept
Concept |  | 514 |  | Version: SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) | Added this Concept
Concept |  | 515 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) | Added this Concept
Concept |  | 516 |  | Version: SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | Added this Concept
Concept |  | 517 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) | Added this Concept
Concept |  | 518 |  | Version: SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | Added this Concept
Concept |  | 519 |  | Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | Added this Concept
Concept |  | 52 |  | Version: hepatitis A vaccine, adult dosage | Added this Concept
Concept |  | 520 |  | Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech | Added this Concept
Concept |  | 521 |  | Version: SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK | Added this Concept
Concept |  | 53 |  | Version: typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | Added this Concept
Concept |  | 54 |  | Version: adenovirus vaccine, type 4, live, oral | Added this Concept
Concept |  | 55 |  | Version: adenovirus vaccine, type 7, live, oral | Added this Concept
Concept |  | 56 |  | Version: dengue fever vaccine, tetravalent | Added this Concept
Concept |  | 62 |  | Version: human papilloma virus vaccine, quadrivalent | Added this Concept
Concept |  | 66 |  | Version: Lyme disease vaccine | Added this Concept
Concept |  | 69 |  | Version: parainfluenza-3 virus vaccine | Added this Concept
Concept |  | 74 |  | Version: rotavirus, live, tetravalent vaccine | Added this Concept
Concept |  | 75 |  | Version: vaccinia (smallpox) vaccine | Added this Concept
Concept |  | 77 |  | Version: Tick-borne encephalitis vaccine (non-US) | Added this Concept
Concept |  | 78 |  | Version: tularemia vaccine | Added this Concept
Concept |  | 80 |  | Version: Venezuelan equine encephalitis, live, attenuated | Added this Concept
Concept |  | 81 |  | Version: Venezuelan equine encephalitis, inactivated | Added this Concept
Concept |  | 82 |  | Version: adenovirus vaccine, unspecified formulation | Added this Concept
Concept |  | 83 |  | Version: hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | Added this Concept
Concept |  | 84 |  | Version: hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | Added this Concept
Concept |  | 85 |  | Version: hepatitis A vaccine, unspecified formulation | Added this Concept
Concept |  | 88 |  | Version: influenza virus vaccine, unspecified formulation | Added this Concept
Concept |  | 89 |  | Version: poliovirus vaccine, unspecified formulation | Added this Concept
Concept |  | 90 |  | Version: rabies vaccine, unspecified formulation | Added this Concept
Concept |  | 91 |  | Version: typhoid vaccine, unspecified formulation | Added this Concept
Concept |  | 92 |  | Version: Venezuelan equine encephalitis vaccine, unspecified formulation | Added this Concept
Concept |  | 94 |  | Version: measles, mumps, rubella, and varicella virus vaccine | Added this Concept
include | urn:oid:1.2.36.1.2001.1005.17 |  |  |  | Removed Include

### Expansion

Unable to generate expansion - see errors